FR2415103A1 - Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments - Google Patents

Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments

Info

Publication number
FR2415103A1
FR2415103A1 FR7900974A FR7900974A FR2415103A1 FR 2415103 A1 FR2415103 A1 FR 2415103A1 FR 7900974 A FR7900974 A FR 7900974A FR 7900974 A FR7900974 A FR 7900974A FR 2415103 A1 FR2415103 A1 FR 2415103A1
Authority
FR
France
Prior art keywords
acids
pyridone
derivatives
preparation
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7900974A
Other languages
English (en)
French (fr)
Other versions
FR2415103B1 (US07655688-20100202-C00086.png
Inventor
Alexander Eduard Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH51278A external-priority patent/CH639073A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2415103A1 publication Critical patent/FR2415103A1/fr
Application granted granted Critical
Publication of FR2415103B1 publication Critical patent/FR2415103B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7900974A 1978-01-18 1979-01-16 Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments Granted FR2415103A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH51278A CH639073A5 (en) 1978-01-18 1978-01-18 4-Pyridone-3-carboxylic acid derivatives and their preparation
CH1173478 1978-11-15

Publications (2)

Publication Number Publication Date
FR2415103A1 true FR2415103A1 (fr) 1979-08-17
FR2415103B1 FR2415103B1 (US07655688-20100202-C00086.png) 1982-11-05

Family

ID=25684790

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900974A Granted FR2415103A1 (fr) 1978-01-18 1979-01-16 Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments

Country Status (25)

Country Link
US (2) US4521535A (US07655688-20100202-C00086.png)
EP (1) EP0003144B1 (US07655688-20100202-C00086.png)
JP (1) JPS54100382A (US07655688-20100202-C00086.png)
KR (1) KR820002111B1 (US07655688-20100202-C00086.png)
AR (1) AR223663A1 (US07655688-20100202-C00086.png)
AT (1) AT369731B (US07655688-20100202-C00086.png)
AU (1) AU521148B2 (US07655688-20100202-C00086.png)
CA (1) CA1110234A (US07655688-20100202-C00086.png)
DE (1) DE2901868A1 (US07655688-20100202-C00086.png)
DK (1) DK20279A (US07655688-20100202-C00086.png)
ES (1) ES476917A1 (US07655688-20100202-C00086.png)
FI (1) FI790103A (US07655688-20100202-C00086.png)
FR (1) FR2415103A1 (US07655688-20100202-C00086.png)
GB (1) GB2013190B (US07655688-20100202-C00086.png)
GR (1) GR73088B (US07655688-20100202-C00086.png)
HU (1) HU179487B (US07655688-20100202-C00086.png)
IE (1) IE47784B1 (US07655688-20100202-C00086.png)
IL (1) IL56421A (US07655688-20100202-C00086.png)
LU (1) LU80794A1 (US07655688-20100202-C00086.png)
MC (1) MC1239A1 (US07655688-20100202-C00086.png)
NL (1) NL7900264A (US07655688-20100202-C00086.png)
NO (1) NO152089C (US07655688-20100202-C00086.png)
NZ (1) NZ189379A (US07655688-20100202-C00086.png)
PT (1) PT69093A (US07655688-20100202-C00086.png)
SE (1) SE7900318L (US07655688-20100202-C00086.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125762A (en) * 1979-07-13 1982-06-15 Alexander E. Wick Dihydronicotinic acid derivatives and process for the preparation thereof
AU539399B2 (en) * 1980-05-12 1984-09-27 Zeneca Limited Substituted oxonicotinates
US4964896A (en) * 1980-05-12 1990-10-23 Monsanto Company Certain-2,6-diphenyl-1,4-dihydro-4-oxo-nicotinates which are useful for inducing male sterility in cereal grain plants
US4714492A (en) * 1980-05-12 1987-12-22 Rohm And Haas Company Certain 2-phenyl-4-oxo-nicotinates and their use for inducing male sterility in a cereal grain plant
US4936904A (en) * 1980-05-12 1990-06-26 Carlson Glenn R Aryl-4-oxonicotinates useful for inducing male sterility in cereal grain plants
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5980665A (ja) * 1982-10-29 1984-05-10 Toyama Chem Co Ltd 4−オキソ−1,4−ジヒドロニコチン酸誘導体
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben
GB8502424D0 (en) * 1985-01-31 1985-03-06 Pharis R P Promotion of flowering fruit trees
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
EP2149547A1 (en) * 2008-07-30 2010-02-03 LEK Pharmaceuticals D.D. Process for the synthesis of ezetimibe and intermediates useful therefor
WO2015099107A1 (ja) 2013-12-26 2015-07-02 塩野義製薬株式会社 含窒素6員環誘導体およびそれらを含有する医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
IN142614B (US07655688-20100202-C00086.png) * 1974-08-28 1977-08-06 Lilly Co Eli
CA1125762A (en) * 1979-07-13 1982-06-15 Alexander E. Wick Dihydronicotinic acid derivatives and process for the preparation thereof
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben

Also Published As

Publication number Publication date
NZ189379A (en) 1984-07-06
US4521535A (en) 1985-06-04
IE47784B1 (en) 1984-06-13
AT369731B (de) 1983-01-25
IL56421A0 (en) 1979-03-12
GB2013190A (en) 1979-08-08
EP0003144A2 (de) 1979-07-25
MC1239A1 (fr) 1979-10-26
PT69093A (en) 1979-02-01
AU521148B2 (en) 1982-03-18
DK20279A (da) 1979-07-19
ATA35079A (de) 1982-06-15
DE2901868A1 (de) 1979-07-19
LU80794A1 (de) 1980-02-14
AR223663A1 (es) 1981-09-15
EP0003144A3 (en) 1979-08-08
IL56421A (en) 1982-08-31
NO152089B (no) 1985-04-22
JPS54100382A (en) 1979-08-08
CA1110234A (en) 1981-10-06
NL7900264A (nl) 1979-07-20
AU4329679A (en) 1979-07-26
GR73088B (US07655688-20100202-C00086.png) 1984-02-01
SE7900318L (sv) 1979-07-19
EP0003144B1 (de) 1981-08-05
FI790103A (fi) 1979-07-19
NO152089C (no) 1985-08-14
KR820002111B1 (ko) 1982-11-10
HU179487B (en) 1982-10-28
GB2013190B (en) 1982-07-14
FR2415103B1 (US07655688-20100202-C00086.png) 1982-11-05
US4549022A (en) 1985-10-22
IE790113L (en) 1979-07-18
ES476917A1 (es) 1979-11-16
NO790165L (no) 1979-07-19

Similar Documents

Publication Publication Date Title
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
FR2390428A1 (fr) Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2400512A1 (fr) Nouveaux nitro-imidazoles, leur preparation et leur application en tant que medicaments
FR2422620A1 (fr) Derives du stilbene, leur preparation et leur application en tant que medicaments
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
FR2360601A1 (fr) Nouveaux derives d'acides phosphoneux, leur preparation et leur application en tant que medicaments
FR2370732A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
FR2415103A1 (fr) Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2355007A1 (fr) (3-alcoyle inferieur-amino-2-r, 10 propoxy pyridines substituees, leur preparation et leur application en tant que medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2355012A1 (fr) Nouveaux derives de dihydro- et tetrahydro-iminothiazine, et leur application en tant que medicaments
FR2379538A1 (fr) Nouveaux derives d'oxadiazolopyrimidine, leur preparation et leur application en tant que medicaments
FR2401160A1 (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
FR2419928A1 (fr) Nouveaux derives de la n-phenylalanine, leur preparation et leur application comme medicaments
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2367061A1 (fr) Nouveaux derives de l'acide 13-thiaprostanoique, leur preparation et leur application en tant que medicaments
FR2396748A1 (fr) Nouveaux derives de prostaglandine, leur preparation et leur application en tant que medicaments
FR2384767A1 (fr) Nouveaux derives d'acides benzo-heteroxyclylglyoxyliques, leur preparation et leur application en tant que medicament
FR2432506A1 (fr) Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
ST Notification of lapse